サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1494343

北米の流動性止血剤市場の2028年までの予測- 地域別分析- 材料、製品、用途、エンドユーザー別

North America Flowable Hemostats Market Forecast to 2028 - Regional Analysis - by Material, Product, Application, and End User

出版日
ページ情報
英文 122 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
北米の流動性止血剤市場の2028年までの予測- 地域別分析- 材料、製品、用途、エンドユーザー別
出版日: 2024年03月14日
発行: The Insight Partners
ページ情報: 英文 122 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

北米の流動性止血剤市場は、2022年の4億9,474万米ドルから2028年には7億4,249万米ドルに成長すると予測されています。2022年から2028年までのCAGRは7.0％と推定されます。

製品の革新をもたらす研究開発活動が北米の流動性止血剤市場を牽引

止血剤製品はヘルスケア業界で高い需要があります。過去数年間、多くの止血剤が開発され、いくつかの外科手術に利用されてきました。研究開発者は集中的な研究開発活動を行っており、その結果、製品の革新がもたらされています。例えば、2019年12月、エチコン（ジョンソン・エンド・ジョンソン医療機器企業）の新製品、"SURGIFLO Hemostatic Matrix"。SURGIFLOW流動性止血製品は、手術中の出血を止め、FLOSEAL（バクスター社製）よりも速いです。さらに2018年1月、止血デバイスの開発・販売大手であるZ-Medica, LLCは、人命救助に役立ち、全国の病院のアンメットニーズを満たすQuikClot Control+を発表しました。QuikClot Control+は、クラスIIIまたはクラスIVの出血を示す患者の内臓腔出血の一時的コントロールに適応されます。また、手術創や外傷などの重度の出血創のコントロールにも使用できます。このように、製品のイノベーションにつながる研究開発活動は、予測期間中に流動性止血剤市場全体の成長に弾みをつけると予測されます。

北米の流動性止血剤市場概要

止血剤製品はヘルスケア業界で高い需要があります。過去数年間、多くの止血剤製品が開発され、いくつかの外科手術に利用されてきました。研究開発者は集中的な研究開発活動を実施しており、その結果、製品の革新がもたらされています。例えば、2019年12月、エチコン（ジョンソン・エンド・ジョンソン医療機器企業）の新製品、"SURGIFLO Hemostatic Matrix"。SURGIFLOW流動性止血製品は、手術中の出血を止め、FLOSEAL（バクスター社製）よりも速いです。さらに2018年1月、止血デバイスの開発・販売大手であるZ-Medica, LLCは、人命救助に役立ち、全国の病院のアンメットニーズを満たすQuikClot Control+を発表しました。QuikClot Control+は、クラスIIIまたはクラスIVの出血を示す患者の内臓腔出血の一時的コントロールに適応されます。また、手術創や外傷などの重度の出血創のコントロールにも使用できます。このように、製品のイノベーションにつながる研究開発活動は、予測期間中に流動性止血剤市場全体の成長に弾みをつけると予測されます。

北米の流動性止血剤市場の収益と2028年までの予測（金額）

北米の流動性止血剤市場のセグメンテーション

北米の流動性止血剤市場は、材料、製品、用途、エンドユーザー、国に区分されます。

材料別では、北米の流動性止血剤市場は牛ゼラチンと豚ゼラチンに二分されます。2022年の北米の流動性止血剤市場では、牛ゼラチン分野が大きなシェアを占めています。

製品別では、北米の流動性止血剤市場は、コンビネーション止血剤、パッシブ止血剤、アクティブ止血剤に区分されます。2022年の北米の流動性止血剤市場では、コンビネーション止血剤セグメントが最大のシェアを占めています。

用途別では、北米の流動性止血剤市場は一般外科、心臓外科、血管外科、整形外科、神経・脊椎外科、その他に分類されます。2022年の北米の流動性止血剤市場では、一般外科分野が最大シェアを占めています。

エンドユーザー別に見ると、北米の流動式止血剤市場は病院・診療所、外来手術センター、その他に区分されます。2022年の北米流動式止血剤市場では、病院・診療所市場が最大シェアを占めています。

国別では、北米の流動性止血剤市場は米国、カナダ、メキシコに分類されます。米国は2022年に北米の流動性止血剤市場を独占しました。

Baxter International Inc、Ethicon（Johnson &Johnson）、Pfizer Inc、Teleflex Incorporated、3-D Matrix Medical Technology、Biom'up、Aegis Lifesciencesは、北米の流動式止血剤市場で事業を展開する大手企業の一部です。

目次

第1章 イントロダクション

第2章 要点

第3章 調査手法

  • カバー範囲
  • 2次調査
  • 1次調査

第4章 北米の流動性止血剤市場- 市場情勢

  • 概観
  • 北米PEST分析
    • 北米のPEST分析
  • 北米の専門家の見解

第5章 北米の流動性止血剤市場：主要市場力学

  • 市場促進要因
    • 怪我や外科手術の増加
    • 老人人口の増加
  • 市場抑制要因
    • 熟練専門家の不足と不十分な償還政策
  • 市場機会
    • 病院数と手術センター数の増加
  • 今後の動向
    • 製品革新につながる研究開発（R&D）活動
  • 影響分析

第6章 流動性止血剤の北米市場分析

  • 北米の流動性止血剤市場収益と分析

第7章 北米の流動性止血剤市場収益予測と分析

  • 北米の流動性止血剤市場分析-素材別
  • 北米の流動性止血剤市場：材料別シェア（2021年、2028年）
  • 牛ゼラチン
    • 牛ゼラチン：北米の流動性止血剤市場-2028年までの収益と予測
  • 豚ゼラチン
    • 豚ゼラチン：北米の流動性止血剤市場-2028年に至る収益と予測

第8章 流動性止血剤の北米市場：製品別

  • 北米の流動性止血剤市場：製品別シェア（2021年、2028年）
  • コンビネーション止血剤
    • コンビネーション止血剤北米の流動性止血剤市場-2028年までの収益と予測
  • パッシブ止血剤
    • パッシブ止血剤北米の流動性止血剤の市場-2028年までの収益と予測
  • 活性型止血剤
    • 活性止血剤：北米の流動性止血剤市場-2028年までの収益と予測

第9章 流動性止血剤の北米市場-用途別

  • 北米の流動性止血剤市場：用途別シェア（2021年、2028年）
  • 一般外科
    • 一般外科北米の流動性止血剤市場-2028年までの収益と予測
  • 心臓外科
    • 心臓外科の概要
    • 心臓外科北米の流動性止血剤市場：収益と2028年までの予測
  • 血管外科
    • 血管外科の概要
    • 血管外科北米の流動性止血剤の市場：収益と2028年までの予測
  • 整形外科
    • 整形外科の概要
    • 整形外科北米の流動性止血剤市場：収益と2028年までの予測
  • 神経・脊椎外科
    • 神経外科と脊椎外科北米の流動性止血剤の市場：収益と2028年までの予測
  • その他
    • その他
    • その他北米の流動性止血剤市場：2028年に至る収益と予測

第10章 流動性止血剤の北米市場分析：エンドユーザー別

  • 北米の流動性止血剤市場：エンドユーザー別シェア（2021年、2028年）
  • 病院および診療所
  • 外来手術センター
  • その他

第11章 北米の流動性止血剤市場の収益と2028年までの予測：国別分析

  • 北米
    • 米国
    • カナダ
    • メキシコ

第12章 北米の流動性止血剤市場-業界情勢

  • 流動性止血剤市場における成長戦略（%）
  • 有機的展開
  • 無機的展開

第13章 企業プロファイル

  • Baxter International Inc
  • Ethicon（Johnson & Johnson）
  • Pfizer Inc.
  • Teleflex Incorporated
  • 3-D Matrix Medical Technology
  • Biom'up
  • Aegis Lifesciences

第14章 付録

図表

List Of Tables

  • Table 1. US: Flowable Hemostats Market, by Material - Revenue and Forecast to 2028 (USD Million)
  • Table 2. US: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
  • Table 3. US: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
  • Table 4. US: Flowable Hemostats Market, End User - Revenue and Forecast to 2028 (USD Million)
  • Table 5. Canada: Flowable Hemostats Market, by Material - Revenue and Forecast to 2028 (USD Million)
  • Table 6. Canada: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
  • Table 7. Canada: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
  • Table 8. Canada: Flowable Hemostats Market, End User - Revenue and Forecast to 2028 (USD Million)
  • Table 9. Mexico: Flowable Hemostats Market, by Material - Revenue and Forecast to 2028 (USD Million)
  • Table 10. Mexico: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
  • Table 11. Mexico: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
  • Table 12. Mexico: Flowable Hemostats Market, End User - Revenue and Forecast to 2028 (USD Million)
  • Table 13. Organic Developments in the Flowable Hemostats Market
  • Table 14. Inorganic Developments in the Flowable Hemostats Market
  • Table 15. North America Glossary of Terms

List Of Figures

  • Figure 1. North America Flowable Hemostats Market Segmentation
  • Figure 2. North America Flowable Hemostats Market, By Country
  • Figure 3. North America Flowable Hemostats Market Overview
  • Figure 4. Bovine Gelatin Holds Maximum Share in North America Flowable Hemostats Market
  • Figure 5. North America Flowable Hemostats Market, by Country (US$ Million)
  • Figure 6. North America Flowable Hemostats Market, Market Attractiveness
  • Figure 7. North America: PEST Analysis
  • Figure 8. North America Experts Opinion
  • Figure 9. Impact Analysis
  • Figure 10. North America Flowable Hemostats Market - Revenue Forecast and Analysis - 2020- 2028
  • Figure 11. North America Flowable Hemostats market Share, by Material, 2021 and 2028 (%)
  • Figure 12. Bovine Gelatin: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 13. Porcine Gelatin: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 14. North America Flowable Hemostats Market Share, by Product, 2021 and 2028 (%)
  • Figure 15. Combination Hemostat: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 16. Passive Hemostat: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 17. Active Hemostat: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 18. North America Flowable Hemostats Market Share, by Application, 2021 and 2028 (%)
  • Figure 19. General Surgery: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 20. Cardiac Surgery: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 21. Vascular Surgery: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 22. Orthopedic Surgery: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 23. Neuro and Spine Surgery: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 24. Others: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 25. North America Flowable Hemostats Gown Market Share, by End User, 2021 and 2028 (%)
  • Figure 26. Hospitals and Clinics: North America Flowable Hemostats Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 27. Ambulatory Surgery Centers: North America Flowable Hemostats Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 28. Others: North America Flowable Hemostats Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 29. North America Flowable Hemostats Market Revenue Overview, by Country, 2021 (US$ MN)
  • Figure 30. North America: Flowable Hemostats Market, by Country, 2022 & 2028 (%)
  • Figure 31. US: Flowable Hemostats Market Revenue and Forecast to 2028 (US$ Mn)
  • Figure 32. Canada: Flowable Hemostats Market Revenue and Forecast to 2028 (US$ Mn)
  • Figure 33. Mexico: Flowable Hemostats Market Revenue and Forecast to 2028 (US$ Mn)
  • Figure 34. Growth Strategies in the Flowable Hemostats Market (%)
目次
Product Code: BMIRE00029826

The North America flowable hemostats market is expected to grow from US$ 494.74 million in 2022 to US$ 742.49 million by 2028. It is estimated to grow at a CAGR of 7.0% from 2022 to 2028.

Research and Development (R&D) Activities Leading to Product Innovations Fuel North America Flowable Hemostats Market

Hemostat products are high in demand in the healthcare industry. Over the past several years, many hemostat products have been developed and utilized in several surgical procedures. Researchers are carrying out intensive research and development activities resulting in product innovations. For Instance, In December 2019, Ethicon's (Johnson & Johnson Medical Device Companies) new product, "SURGIFLO Hemostatic Matrix." SURGIFLOW flowable hemostatic product stops bleeding while performing surgery and is faster than FLOSEAL (manufactured by Baxter). Furthermore, In January 2018, Z-Medica, LLC, a leading developer and marketer of hemostatic devices introduced QuikClot Control+ which can help save lives and fill the unmet need of hospitals across the country. QuikClot Control+ is indicated for temporary control of internal organ space bleeding for patients displaying class III or class IV bleeding. It may even be used to control severe bleeding wounds such as surgical wounds and traumatic injuries. Thus, research and development activities leading to product innovations are predicted to deliver an impetus for the growth of the overall flowable hemostats market during the forecast period.

North America Flowable Hemostats Market Overview

Hemostat products are high in demand in the healthcare industry. Over the past several years, many hemostat products have been developed and utilized in several surgical procedures. Researchers are carrying out intensive research and development activities resulting in product innovations. For Instance, In December 2019, Ethicon's (Johnson & Johnson Medical Device Companies) new product, "SURGIFLO Hemostatic Matrix." SURGIFLOW flowable hemostatic product stops bleeding while performing surgery and is faster than FLOSEAL (manufactured by Baxter). Furthermore, In January 2018, Z-Medica, LLC, a leading developer and marketer of hemostatic devices introduced QuikClot Control+ which can help save lives and fill the unmet need of hospitals across the country. QuikClot Control+ is indicated for temporary control of internal organ space bleeding for patients displaying class III or class IV bleeding. It may even be used to control severe bleeding wounds such as surgical wounds and traumatic injuries. Thus, research and development activities leading to product innovations are predicted to deliver an impetus for the growth of the overall flowable hemostats market during the forecast period.

North America Flowable Hemostats Market Revenue and Forecast to 2028 (US$ Million)

North America Flowable Hemostats Market Segmentation

The North America flowable hemostats market is segmented into material, product, application, end user, and country.

Based on material, the North America flowable hemostats market is bifurcated into bovine gelatin & porcine gelatin. The bovine gelatin segment held a larger share of the North America flowable hemostats market in 2022.

In terms of product, the North America flowable hemostats market is segmented into combination hemostats, passive hemostats, and active hemostats. The combination hemostats segment held the largest share of the North America flowable hemostats market in 2022.

Based on Application, the North America flowable hemostats market is categorized into general surgery, cardiac surgery, vascular surgery, orthopedic surgery, neuro and spine surgery, and others. The general surgery segment held the largest share of the North America flowable hemostats market in 2022.

Based on end user, the North America flowable hemostats market is segmented into hospitals and clinics, ambulatory surgery centers, and others. The hospitals and clinics segment held the largest share of the North America flowable hemostats market in 2022.

By country, the North America flowable hemostats market is categorized into the US, Canada, and Mexico. The US dominated the North America flowable hemostats market in 2022.

Baxter International Inc, Ethicon (Johnson & Johnson), Pfizer Inc, Teleflex Incorporated, 3-D Matrix Medical Technology, Biom'up, and Aegis Lifesciences are some of the leading companies operating in the North America North America flowable hemostats market.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 North America Flowable Hemostats Market - By Material
    • 1.3.2 North America Flowable Hemostats Market - By Product
    • 1.3.3 North America Flowable Hemostats Market - By Application
    • 1.3.4 North America Flowable Hemostats Market - By End User
    • 1.3.5 North America Flowable Hemostats Market - By Country

2. Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Flowable Hemostats Market - Market Landscape

  • 4.1 Overview
  • 4.2 North America PEST Analysis
    • 4.2.1 North America PEST Analysis
  • 4.3 North America Experts Opinion

5. North America Flowable Hemostats Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Increasing Number of Injuries and Surgical Procedures
    • 5.1.2 Rising Geriatric Population
  • 5.2 Market Restraints
    • 5.2.1 Shortage of Skilled Professionals and Poor Reimbursement Policies
  • 5.3 Market Opportunities
    • 5.3.1 Increasing Number of Hospitals and Surgical Centers
  • 5.4 Future Trends
    • 5.4.1 Research and Development (R&D) Activities Leading to Product Innovations
  • 5.5 Impact Analysis

6. Flowable Hemostats Market - North America Analysis

  • 6.1 North America Flowable Hemostats Market Revenue Forecast & Analysis

7. North America Flowable Hemostats Market Revenue Forecast & Analysis

  • 7.1 North America Flowable Hemostats Market Analysis - By Material
  • 7.2 North America Flowable Hemostats Market Share, by Material, 2021 and 2028 (%)
  • 7.3 Bovine Gelatin
    • 7.3.1 Overview
    • 7.3.2 Bovine Gelatin: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • 7.4 Porcine Gelatin
    • 7.4.1 Overview
    • 7.4.2 Porcine Gelatin: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)

8. North America Flowable Hemostats Market- By Product

  • 8.1 Overview
  • 8.2 North America Flowable Hemostats Market Share, by Product, 2021 and 2028 (%)
  • 8.3 Combination Hemostat
    • 8.3.1 Overview
    • 8.3.2 Combination Hemostat: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • 8.4 Passive Hemostat
    • 8.4.1 Overview
    • 8.4.2 Passive Hemostat: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • 8.5 Active Hemostat
    • 8.5.1 Overview
    • 8.5.2 Active Hemostat: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)

9. North America Flowable Hemostats Market- By Application

  • 9.1 Overview
  • 9.2 North America Flowable Hemostats Market Share, by Application, 2021 and 2028 (%)
  • 9.3 General Surgery
    • 9.3.1 Overview
    • 9.3.2 General Surgery: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • 9.4 Cardiac Surgery
    • 9.4.1 Overview
    • 9.4.2 Cardiac Surgery: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • 9.5 Vascular Surgery
    • 9.5.1 Overview
    • 9.5.2 Vascular Surgery: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • 9.6 Orthopedic Surgery
    • 9.6.1 Overview
    • 9.6.2 Orthopedic Surgery: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • 9.7 Neuro and Spine Surgery
    • 9.7.1 Overview
    • 9.7.2 Neuro and Spine Surgery: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • 9.8 Others
    • 9.8.1 Overview
    • 9.8.2 Others: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)

10. North America Flowable Hemostats Market Analysis - By End User

  • 10.1 Overview
  • 10.2 North America Flowable Hemostats Market Share, by End User, 2021 and 2028, (%)
  • 10.3 Hospitals and Clinics
    • 10.3.1 Overview
    • 10.3.2 Hospitals and Clinics: North America Flowable Hemostats Market - Revenue and Forecast to 2028 (US$ Million)
  • 10.4 Ambulatory Surgery Centers
    • 10.4.1 Overview
    • 10.4.2 Ambulatory Surgery Centers: North America Flowable Hemostats Market - Revenue and Forecast to 2028 (US$ Million)
  • 10.5 Others
    • 10.5.1 Overview
    • 10.5.2 Others: North America Flowable Hemostats Market - Revenue and Forecast to 2028 (US$ Million)

11. North America Flowable Hemostats Market Revenue and Forecasts to 2028 - Country Analysis

  • 11.1 North America: Flowable Hemostats Market
    • 11.1.1 Overview
    • 11.1.2 North America: Flowable Hemostats Market, by Country, 2022 & 2028 (%)
      • 11.1.2.1 US: Flowable Hemostats Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.1.2.1.1 Overview
      • 11.1.2.2 US: Flowable Hemostats Market - Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.2.1 US: Flowable Hemostats Market, by Material- Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.2.2 US: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.2.3 US: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.2.4 US: Flowable Hemostats Market, End User - Revenue and Forecast to 2028 (USD Million)
      • 11.1.2.3 Canada: Flowable Hemostats Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.1.2.3.1 Overview
        • 11.1.2.3.2 Canada: Flowable Hemostats Market - Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.3.3 Canada: Flowable Hemostats Market, by Material- Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.3.4 Canada: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.3.5 Canada: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.3.6 Canada: Flowable Hemostats Market, End User - Revenue and Forecast to 2028 (USD Million)
      • 11.1.2.4 Mexico: Flowable Hemostats Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.1.2.4.1 Overview
        • 11.1.2.4.2 Mexico: Flowable Hemostats Market - Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.4.3 Mexico: Flowable Hemostats Market, by Material- Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.4.4 Mexico: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.4.5 Mexico: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.4.6 Mexico: Flowable Hemostats Market, End User - Revenue and Forecast to 2028 (USD Million)

12. North America Flowable Hemostats Market-Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in the Flowable Hemostats Market (%)
  • 12.3 Organic Developments
    • 12.3.1 Overview
  • 12.4 Inorganic Developments
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 Baxter International Inc
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Ethicon (Johnson & Johnson)
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Pfizer Inc.
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Teleflex Incorporated
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 3-D Matrix Medical Technology
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Biom'up
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Aegis Lifesciences
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 North America Glossary of Terms